Titan Biotech Limited (BOM:524717)
297.80
+21.55 (7.80%)
At close: Mar 9, 2026
Titan Biotech Market Cap
Titan Biotech has a market cap or net worth of 12.3 billion as of March 9, 2026. Its market cap has increased by 240.93% in one year.
Market Cap
12.30B
Enterprise Value
12.36B
Revenue
1.93B
Ranking
n/a
PE Ratio
45.24
Stock Price
297.80
Market Cap Chart
Since December 22, 2000, Titan Biotech's market cap has increased from 100.53M to 12.30B, an increase of 12,140.09%. That is a compound annual growth rate of 20.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 12.30B | 41.30% |
| Dec 31, 2025 | 8.71B | 43.81% |
| Dec 31, 2024 | 6.06B | 78.89% |
| Dec 29, 2023 | 3.38B | 37.68% |
| Dec 30, 2022 | 2.46B | 0.42% |
| Dec 31, 2021 | 2.45B | 98.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hester Biosciences | 12.63B |
| Asian Hotels (North) | 12.59B |
| R & B Denims | 12.54B |
| Southern Petrochemical Industries Corporation | 12.51B |
| Chaman Lal Setia Exports | 12.50B |
| TTK Healthcare | 12.47B |
| Ultramarine & Pigments | 12.46B |
| GOCL Corporation | 12.37B |